Cargando…
Oral oncolytic and antiretroviral therapy administration: dose adjustments, drug interactions, and other considerations for clinical use
The rise in non-AIDS defining cancers (NADCs) is emerging as a leading cause of death for HIV and cancer patients. To address this, current literature and guidelines suggest the continuation of antiretroviral therapy (ART) with oral oncolytic agents to prevent adverse complications associated with H...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioExcel Publishing Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383448/ https://www.ncbi.nlm.nih.gov/pubmed/30815023 http://dx.doi.org/10.7573/dic.212550 |